Investors

View Stock Information
Corporate presentation image
Corporate Presentation (PDF)

Corporate Profile

Sernova is a regenerative medicine company developing therapeutic technologies with multibillion-dollar market potential for each of its clinical indications.

Press Releases

April 17, 2025
Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans
April 15, 2025
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
April 1, 2025
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes
View All Press Releases

Events

January 10, 2025
Annual General and Special Meeting of Shareholders
December 13, 2024 ET
Sernova Virtual Investor Event: Meet Our Leadership
View All Events

IR Contact


David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Scroll to Top